Phenotype
|
Fish
|
Conditions
|
Figures
|
autophagy process quality, ameliorated
|
AB + MO1-ambra1a
|
chemical treatment by injection: trehalose
|
Fig. 4
from Ye et al., 2020
|
muscle mitochondrion morphology, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 8
from Skobo et al., 2014
|
trunk musculature muscle cell disorganized, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 4
from Skobo et al., 2014
|
thigmotaxis disrupted, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. S4
from Skobo et al., 2014
|
head morphology, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Ye et al., 2020
|
whole organism refractivity, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
|
muscle cell nucleus morphology, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 4 ,
Fig. 8
from Skobo et al., 2014
|
myoseptum unstructured, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 4
from Skobo et al., 2014
|
somite morphology, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 2
from Skobo et al., 2014
|
muscle sarcomere disorganized, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
somite shape, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 9
from Skobo et al., 2014
|
trunk curved, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Ye et al., 2020
|
pericardial cavity increased size, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Ye et al., 2020
|
muscle disorganized, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
myoseptum morphology, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3 ,
Fig. 9
from Skobo et al., 2014
|
swimming process quality, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. S4
from Skobo et al., 2014
|
whole organism anterior-posterior axis decreased length, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Ye et al., 2020
|
muscle striated muscle thin filament separated from muscle myosin filament, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 8
from Skobo et al., 2014
|
cell population proliferation increased occurrence, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 5
from Skobo et al., 2014
|
autophagy disrupted, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 4
from Ye et al., 2020
|
myosin filament organization disrupted, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 9
from Skobo et al., 2014
|
pericardial cavity hemorrhagic, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Ye et al., 2020
|
hatching disrupted, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. S3
from Skobo et al., 2014
|
whole organism decreased size, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
|
skeletal myofibril assembly disrupted, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 9
from Skobo et al., 2014
|
muscle cell disorganized, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3 ,
Fig. 8 ,
Fig. 9
from Skobo et al., 2014
|
muscle cell nucleus increased amount, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Skobo et al., 2014
|
muscle sarcoplasmic reticulum dilated, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 8
from Skobo et al., 2014
|
post-vent region curved, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
|
whole organism anterior-posterior axis shortened, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 2
from Skobo et al., 2014
|
muscle sarcomere decreased amount, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
embryo development disrupted, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
|
muscle cell degenerate, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
notochord undulate, abnormal
|
AB + MO1-ambra1a
|
standard conditions
|
Fig. 2
from Skobo et al., 2014
|
heart edematous, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 1
from Meneghetti et al., 2020
|
heart tube malformed, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 1 ,
Fig. 2
from Meneghetti et al., 2020
|
head decreased size, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
notochord disorganized, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|
embryonic heart tube left/right pattern formation disrupted, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 2
from Meneghetti et al., 2020
|
head apoptotic, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 12
from Benato et al., 2013
|
cell population proliferation increased occurrence, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 4
from Meneghetti et al., 2020
|
apoptotic process increased occurrence, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 12
from Benato et al., 2013
|
post-vent region deformed, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|
whole organism deformed, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
post-vent region kinked, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
trunk decreased size, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
Rohon-Beard neuron mislocalised, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 2
from Meneghetti et al., 2020
|
heart looping disrupted, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 2
from Meneghetti et al., 2020
|
tectal ventricle hydrocephalic, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|
autophagy decreased process quality, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 11
from Benato et al., 2013
|
eye decreased size, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6,
Fig. 7,
Fig. 8
from Benato et al., 2013
|
pigmentation delayed, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
embryo development disrupted, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
yolk syncytial layer edematous, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 8
from Benato et al., 2013
|
otolith decreased size, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
embryonic heart tube development disrupted, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 1 ,
Fig. 2
from Meneghetti et al., 2020
|
fourth ventricle hydrocephalic, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|
pericardium edematous, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 8
from Benato et al., 2013
|
subintestinal vein morphology, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. S3
from Benato et al., 2013
|
otic vesicle decreased size, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. 8
from Benato et al., 2013
|
whole organism dead, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
text only
from Benato et al., 2013
|
intersegmental vessel morphology, abnormal
|
WT + MO1-ambra1a
|
standard conditions
|
Fig. S3
from Benato et al., 2013
|
eye decreased size, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
pigmentation delayed, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
head decreased size, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
trunk decreased size, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
post-vent region kinked, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
whole organism deformed, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
otolith decreased size, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
embryo development disrupted, abnormal
|
WT + MO1-ambra1a + MO4-tp53
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
embryonic heart tube development disrupted, abnormal
|
ambra1aia35 + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Meneghetti et al., 2020
|
embryonic heart tube left/right pattern formation disrupted, abnormal
|
ambra1aia35 + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Meneghetti et al., 2020
|
heart looping disrupted, abnormal
|
ambra1aia35 + MO1-ambra1a
|
standard conditions
|
Fig. 3
from Meneghetti et al., 2020
|
muscle cell degenerate, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
muscle sarcomere decreased amount, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
muscle sarcomere disorganized, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
trunk musculature muscle cell disorganized, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 4
from Skobo et al., 2014
|
myoseptum unstructured, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 4
from Skobo et al., 2014
|
muscle cell nucleus morphology, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 4 ,
Fig. 8
from Skobo et al., 2014
|
muscle cell disorganized, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 3 ,
Fig. 8 ,
Fig. 9
from Skobo et al., 2014
|
somite morphology, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 2
from Skobo et al., 2014
|
skeletal myofibril assembly disrupted, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 9
from Skobo et al., 2014
|
hatching disrupted, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. S3
from Skobo et al., 2014
|
muscle striated muscle thin filament separated from muscle myosin filament, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 8
from Skobo et al., 2014
|
swimming process quality, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. S4
from Skobo et al., 2014
|
muscle mitochondrion morphology, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 8
from Skobo et al., 2014
|
thigmotaxis disrupted, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. S4
from Skobo et al., 2014
|
muscle disorganized, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Skobo et al., 2014
|
cell population proliferation increased occurrence, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 5
from Skobo et al., 2014
|
somite shape, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 9
from Skobo et al., 2014
|
myoseptum morphology, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 3 ,
Fig. 9
from Skobo et al., 2014
|
notochord undulate, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 2
from Skobo et al., 2014
|
myosin filament organization disrupted, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 9
from Skobo et al., 2014
|
whole organism anterior-posterior axis shortened, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 2
from Skobo et al., 2014
|
muscle cell nucleus increased amount, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 3
from Skobo et al., 2014
|
muscle sarcoplasmic reticulum dilated, abnormal
|
AB + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 8
from Skobo et al., 2014
|
heart tube malformed, exacerbated
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 1
from Meneghetti et al., 2020
|
head decreased size, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
eye decreased size, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 6,
Fig. 7,
Fig. 8
from Benato et al., 2013
|
fourth ventricle hydrocephalic, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|
whole organism deformed, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
whole organism decreased size, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
|
otic vesicle decreased size, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 8
from Benato et al., 2013
|
embryo development disrupted, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
Fig. 6
from Benato et al., 2013
|
otolith decreased size, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
embryonic heart tube development disrupted, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 1
from Meneghetti et al., 2020
|
heart edematous, exacerbated
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 1
from Meneghetti et al., 2020
|
notochord disorganized, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|
whole organism refractivity, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
|
head apoptotic, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 12
from Benato et al., 2013
|
post-vent region curved, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 1
from Skobo et al., 2014
|
apoptotic process increased occurrence, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 12
from Benato et al., 2013
|
intersegmental vessel morphology, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. S3
from Benato et al., 2013
|
eye adjacent to eye, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 8
from Benato et al., 2013
|
tectal ventricle hydrocephalic, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|
subintestinal vein morphology, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. S3
from Benato et al., 2013
|
post-vent region kinked, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 6
from Benato et al., 2013
|
post-vent region deformed, abnormal
|
WT + MO1-ambra1a + MO1-ambra1b
|
standard conditions
|
Fig. 7
from Benato et al., 2013
|